SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* WEST COAST ASSET MANAGEMENT INC (Last) (First) (Middle) 2151 ALESSANDRO DR STE 100 (Street) VENTURA CA 93001 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol ANGIOTECH PHARMACEUTICALS INC [ ANPI ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner Officer (give title below) Other (specify below)
	3. Date of Earliest Transaction (Month/Day/Year) 02/25/2008
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Angiotech Pharmaceuticals, Inc.	02/25/2008		P		255,194	A	$3.19	9,703,225	I	See footnote #1(1)
Angiotech Pharmaceuticals, Inc.	03/19/2008		P		1,114,726	A	$1.6987	11,195,576	I	See footnote #2(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person* WEST COAST ASSET MANAGEMENT INC (Last) (First) (Middle) 2151 ALESSANDRO DR STE 100 (Street) VENTURA CA 93001 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Lowe R Atticus (Last) (First) (Middle) 2151 ALESSANDRO DRIVE SUITE 100 (Street) VENTURA CA 93001 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Helfert Lance W (Last) (First) (Middle) 2151 ALESSANDRO DRIVE SUITE 100 (Street) VENTURA CA 93001 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Orfalea Paul J (Last) (First) (Middle) 2151 ALESSANDRO DRIVE SUITE 100 (Street) VENTURA CA 93001 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

Explanation of Responses:

1. The Reporting Persons may be deemed to be indirect beneficial owners of the shares because WCAM has the power to vote the shares pursuant to investor advisor agreements with the record owners. 2,457,050 shares are held in trust accounts, 655,125 shares are held in IRA accounts, 2,586,500 shares are held in Foundation accounts, 60,600 shares are held in corporate accounts, 3,311,400 shares are held in high net worth individuals' accounts, 193,150 shares are held in LLC accounts, 254,900 shares are held in LP accounts, and 184,500 shares are held in profit sharing accounts (managed by WCAM).

2. The Reporting Persons may be deemed to be indirect beneficial owners of the shares because WCAM has the power to vote the shares pursuant to investor advisor agreements with the record owners. 2,812,000 shares are held in trust accounts, 744,350 shares are held in IRA accounts, 3,040,726 shares are held in Foundation accounts, 72,325 shares are held in corporate accounts, 3,722,800 shares are held in high net worth individuals' accounts, 204,500 shares are held in LLC accounts, 385,100 shares are held in LP accounts, and 213,775 shares are held in profit sharing accounts (managed by WCAM).

	Linda Schuman Attorney-In-Fact	03/24/2008
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.